P Mazzeo

1PUBLICATIONS
8CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 20, 2026
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.

M H Werner, A McGarry, C Meyer

Pageof 1

Frequent Collaborators

1 joint publications

M H Werner

1 joint publications

A McGarry

1 joint publications

K Kieburtz

1 joint publications

R A Hauser